Arrhythmia-induced cardiomyopathy: A potentially reversible cause of refractory cardiogenic shock requiring venoarterial extracorporeal membrane oxygenation
Guillaume Hékimian(Inserm), Charles‐Édouard Luyt(Inserm), Grégoire Müller(Centre hospitalier régional d'Orléans), Paul Masi(Associated Research (United States)), Nicolas Bréchot(Inserm), Guillaume Franchineau(Université Claude Bernard Lyon 1), Xavier Waintraub(Assistance Publique – Hôpitaux de Paris), Estelle Gandjbakhch(Sorbonne Université), Guillaume Lebreton(Inserm), Ania Nieszkowska(Assistance Publique – Hôpitaux de Paris), Simon Bourcier(Sorbonne Université), Pascal Leprince(Sorbonne Université), Nicolas Paulo(Inserm), Alain Combes(Sorbonne Université), Matthieu Schmidt(Inserm), Marc Pineton de Chambrun(Inserm)
Cited by 28
Related Papers
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Ventilator-associated pneumonia in adults: a narrative review
|Intensive Care Medicine|2020|995
Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry
|The Lancet|2020|945
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock
|New England Journal of Medicine|2018|894
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
|Intensive Care Medicine|2023|855